Piro LD - Search Results

1

2-Chlorodeoxyadenosine: an active agent in the treatment of cutaneous T-cell lymphoma.

Saven A, Carrera CJ, Carson DA, Beutler E, Piro LD. Saven A, et al. Among authors: piro ld. Blood. 1992 Aug 1;80(3):587-92. Blood. 1992. PMID: 1353380 Free article.

2

2-Chlorodeoxyadenosine activity in patients with untreated, indolent non-Hodgkin's lymphoma.

Saven A, Emanuele S, Kosty M, Koziol J, Ellison D, Piro L. Saven A, et al. Blood. 1995 Sep 1;86(5):1710-6. Blood. 1995. PMID: 7655003 Free article. Clinical Trial.

3

Cladribine and mitoxantrone dose escalation in indolent non-Hodgkin's lymphoma.

Saven A, Lee T, Kosty M, Piro L. Saven A, et al. J Clin Oncol. 1996 Jul;14(7):2139-44. doi: 10.1200/JCO.1996.14.7.2139. J Clin Oncol. 1996. PMID: 8683247

4

Treatment of hairy cell leukemia.

Saven A, Piro LD. Saven A, et al. Among authors: piro ld. Blood. 1992 Mar 1;79(5):1111-20. Blood. 1992. PMID: 1371410 Free article. Review. No abstract available.

5

2-Chlorodeoxyadenosine chemotherapy triggers programmed cell death in normal and malignant lymphocytes.

Carrera CJ, Piro LD, Saven A, Beutler E, Terai C, Carson DA. Carrera CJ, et al. Among authors: piro ld. Adv Exp Med Biol. 1991;309A:15-8. doi: 10.1007/978-1-4899-2638-8_3. Adv Exp Med Biol. 1991. PMID: 1686349 No abstract available.

6

Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. A novel approach to immunosuppressive therapy.

Carrera CJ, Terai C, Lotz M, Curd JG, Piro LD, Beutler E, Carson DA. Carrera CJ, et al. Among authors: piro ld. J Clin Invest. 1990 Nov;86(5):1480-8. doi: 10.1172/JCI114865. J Clin Invest. 1990. PMID: 1700795 Free PMC article.

7

Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine.

Piro LD, Carrera CJ, Carson DA, Beutler E. Piro LD, et al. N Engl J Med. 1990 Apr 19;322(16):1117-21. doi: 10.1056/NEJM199004193221605. N Engl J Med. 1990. PMID: 1969613 Free article.

8

Profound toxicity of deoxyadenosine and 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo.

Carrera CJ, Yamanaka H, Piro LD, Lotz M, Carson DA. Carrera CJ, et al. Among authors: piro ld. Adv Exp Med Biol. 1989;253B:219-25. doi: 10.1007/978-1-4684-5676-9_33. Adv Exp Med Biol. 1989. PMID: 2575348

9

2-Chlorodeoxyadenosine: an effective new agent for the treatment of chronic lymphocytic leukemia.

Piro LD, Carrera CJ, Beutler E, Carson DA. Piro LD, et al. Blood. 1988 Sep;72(3):1069-73. Blood. 1988. PMID: 2901280 Free article.

10

The Scripps Clinic experience with 2-chlorodeoxyadenosine in the treatment of hairy cell leukemia.

Piro LD, Ellison DJ, Saven A. Piro LD, et al. Leuk Lymphoma. 1994;14 Suppl 1:121-5. Leuk Lymphoma. 1994. PMID: 7820043 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters